Viewing StudyNCT04696731



Ignite Creation Date: 2024-05-06 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04696731
Status: RECRUITING
Last Update Posted: 2023-10-31
First Post: 2021-01-04

Brief Title: Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
Sponsor: Allogene Therapeutics
Organization: Allogene Therapeutics

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-02-24
Start Date Type: ACTUAL
Primary Completion Date: 2025-08
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-10
Completion Date Type: ESTIMATED
First Submit Date: 2021-01-04
First Submit QC Date: January 4 2021
Study First Post Date: 2021-01-06
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-10-30
Last Update Post Date: 2023-10-31
Last Update Post Date Type: ACTUAL